PPI - iRefIndex |
UniProt A | UniProt B | Method | PMID | Interaction Type | Edge type | Num Participants |
P63208-2 | Q9UKT7 | - | 10531035 | - | X | 2 |
A0A024R1Z1 | Q9UKT7 | enzymatic study | 10531035 | direct interaction | X | 2 |
A0A090N7U0 | Q9UKT7 | affinity chromatography technology | 22268729 | physical association | X | 2 |
A0A090N7U0 | Q9UKT7 | affinity chromatography technology | 24085301 | physical association | X | 2 |
A0A090N7U0 | Q9UKT7 | affinity chromatography technology | 10531035 | physical association | X | 2 |
P62324 | Q9UKT7 | affinity chromatography technology | 22975506 | physical association | X | 2 |
Q49AN0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
Q49AN0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
Q49AN0 | Q9UKT7 | enzymatic study | 17463251 | direct interaction | X | 2 |
Q49AN0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
Q49AN0 | Q9UKT7 | affinity chromatography technology | 24085301 | physical association | X | 2 |
A2I2P0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
A2I2P0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
A2I2P0 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
A2I2P0 | Q9UKT7 | affinity chromatography technology | 24085301 | physical association | X | 2 |
Q86VP6 | Q9UKT7 | affinity chromatography technology | 23453757 | physical association | X | 2 |
Q9UKT7 | P07900-2 | affinity chromatography technology | 22939624 | physical association | X | 2 |
Q9UKT7 | P62837 | enzymatic study | 10531035 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | x-ray crystallography | 23503662 | association | X | 2 |
Q9R194 | Q9UKT7 | affinity chromatography technology | 23503662 | physical association | X | 2 |
P0CG48 | Q9UKT7 | affinity chromatography technology | 22505724 | physical association | X | 2 |
P0CG48 | Q9UKT7 | affinity chromatography technology | 21963094 | physical association | X | 2 |
P0CG48 | Q9UKT7 | affinity chromatography technology | 21987572 | physical association | X | 2 |
P0CG48 | Q9UKT7 | affinity chromatography technology | 21890473 | physical association | X | 2 |
P0CG48 | Q9UKT7 | affinity chromatography technology | 21906983 | physical association | X | 2 |
P97784 | Q9UKT7 | affinity chromatography technology | 20360068 | physical association | X | 2 |
P63208 | Q9UKT7 | affinity chromatography technology | 17463251 | physical association | X | 2 |
P63208 | Q9UKT7 | affinity chromatography technology | 24085301 | physical association | X | 2 |
P63208 | Q9UKT7 | affinity chromatography technology | 10531035 | physical association | X | 2 |
P63208 | Q9UKT7 | two hybrid | 10531035 | direct interaction | X | 2 |
P63208 | Q9UKT7 | pull down | 10531035 | direct interaction | X | 2 |
P78543 | Q9UKT7 | affinity chromatography technology | 22975506 | physical association | X | 2 |
| Q9UKT7 | anti tag coimmunoprecipitation | 17463251 | association | C | 4 |
| Q9UKT7 | anti tag coimmunoprecipitation | 17463251 | association | C | 4 |
| Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | - | C | 3 |
| Q9UKT7 | molecular sieving | 23503662 | physical association | C | 3 |
| Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | physical association | C | 3 |
| Q9UKT7 | pull down | 23503662 | physical association | C | 3 |
| Q9UKT7 | x-ray crystallography | 23503662 | physical association | C | 3 |
| Q9UKT7 | ion exchange chromatography | 23503662 | physical association | C | 3 |
| Q9UKT7 | mass spectrometry studies of complexes | 23503662 | physical association | C | 3 |
| Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | - | C | 4 |
| Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | - | C | 5 |
Q9UKT7 | Q9WTX5 | anti tag coimmunoprecipitation | 23503662 | physical association | X | 2 |
Q9UKT7 | Q9WTX5 | anti tag coimmunoprecipitation | 23503662 | physical association | X | 2 |
Q9R194 | Q9UKT7 | mass spectrometry studies of complexes | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | pull down | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | anti tag coimmunoprecipitation | 23503662 | direct interaction | X | 2 |
Q9R194 | Q9UKT7 | pull down | 23503662 | direct interaction | X | 2 |
P63208 | Q9UKT7 | pull down | 23503662 | physical association | X | 2 |
| Q9UKT7 | in vivo | 10531035 | - | C | 3 |
| Q9UKT7 | in vivo | 10531035 | - | C | 3 |
| Q9UKT7 | in vivo | 10531035 | - | C | 3 |
P63208-2 | Q9UKT7 | two hybrid | 10531035 | - | X | 2 |
P63208-2 | Q9UKT7 | in vitro | 10531035 | - | X | 2 |
P63208-2 | Q9UKT7 | in vivo | 10531035 | - | X | 2 |
P63208-2 | Q9UKT7 | two hybrid | 10531035 | - | X | 2 |
P63208-2 | Q9UKT7 | in vivo | 10531035 | - | X | 2 |
P63208-2 | Q9UKT7 | in vitro | 10531035 | - | X | 2 |
| Q9UKT7 | tandem affinity purification | 20360068 | physical association | C | 4 |
P63209 | Q9UKT7 | coimmunoprecipitation | 10531035 | physical association | X | 2 |
P63209 | Q9UKT7 | beta lactamase complementation | 10531035 | physical association | X | 2 |
Q9UKT7 | A0A024RD80 | luminescence based mammalian interactome mapping | 22939624 | physical association | X | 2 |
Q8D131 | Q9UKT7 | two hybrid pooling approach | 20711500 | physical association | X | 2 |